Abstract: A nose fairing (10) is a nose fairing coupled to a main body (12) of a rocket (11) so as to be separable from the main body. The nose fairing includes: a pair of fairing pieces (40, 50) that are separated after a predetermined time has elapsed since the rocket is launched, the pair of fairing pieces being engaged with each other and maintained in a coupled state before the pair of fairing pieces separate; a biasing structure (60) that biases the fairing pieces in a proceeding direction of the rocket to separate the fairing pieces from the main body; and a separating mechanism (13) that releases the engagement between the pair of fairing pieces and separates the pair of fairing pieces in such a manner that a distance of separation of one of the pair of fairing pieces from the main body is made longer than a distance of separation of the other of the pair of fairing pieces from the main body.

Abstract: The object of the present invention is to provide a method for identifying a patient with malignant tumor on which the effect of an immune checkpoint inhibitor can be more expected, and agents for suppressing the progression of, suppressing the recurrence of, and/or treating malignant tumor, characterized by prescriptions based on those. The present invention can provide agents for suppressing the progression of, suppressing the recurrence of, and/or treating malignant tumor, characterized by prescriptions based on identifying a patient with a malignant tumor on which the effect of an immune checkpoint inhibitor can be more expected, by analyzing the evaluation items consisting of combinations such as the PD-1 expression intensity, the percentage of the number of PD-1 expressing cells and the like in Treg cells and CD8+ T cells in tumor tissue or blood.